Voyager Therapeutics, Inc. Common Stock (VYGR) is a publicly traded Healthcare sector company. As of October 21, 2026, VYGR trades at $2.07 with a market cap of $126.32M and a P/E ratio of -1.36. VYGR moved -2.05% today. Year to date, VYGR is -45.66%; over the trailing twelve months it is -56.80%. Its 52-week range spans $1.89 to $5.55. Analyst consensus is strong buy with an average price target of $13.75. Rallies surfaces VYGR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks VYGR insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $2.07 |
| Market Cap | $126.32M |
| P/E Ratio | -1.36 |
| EPS | $-1.81 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.55 |
| 52-Week Low | $1.89 |
| Volume | 190.49K |
| Avg Volume | 0 |
| Revenue (TTM) | $34.46M |
| Net Income | $-107.73M |
| Gross Margin | 0.00% |
5 analysts cover VYGR: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $13.75.